Monthly subscriptions are coming soon.Explore 15% savings
AccountBag
CJCND-PW-10MGResearch material
CJC-1295
Defined materials. Documented research.Product record

Conceptual scientific graphic. Refer to the product and lot record for identity and analytical results.

Find COA / lot documentation

CJC-1295 (no DAC) 10MG

$115.00

CJC-1295 (No DAC) 10MG is a synthetic research peptide intended for controlled laboratory use. Researchers work with this non-DAC peptide in in vitro settings where timing, structure, and short-duration signaling observation are central to study design.

  • Non-DAC research peptide selected for short-acting signaling studies
  • Used in laboratory research examining GHRH-related peptide behavior
  • Supplied in freeze-dried form with verified quality and batch documentation

 

Monthly plan $97.75/ month

Monthly subscriptions are coming soon. See plan details.

In stock

Description

CJC-1295 (No DAC) 10MG for Laboratory Research

CJC-1295 (No DAC) 10MG is a synthetic research peptide used in controlled laboratory settings. Researchers study this peptide as a modified form of growth hormone-releasing hormone (GHRH) to examine signaling activity at the molecular level in non-clinical research models. Because this version does not include a Drug Affinity Complex, it shows a shorter activity window in laboratory studies compared to DAC-based forms.

In research environments, scientists work with this non-DAC peptide to observe signaling patterns over short timeframes. As a result, laboratories include this compound in studies where timing and controlled observation periods are important.

Research Applications for This Non-DAC Peptide

In laboratory research, scientists use this peptide to study GHRH-related signaling pathways under controlled conditions. These studies often focus on receptor interaction, peptide stability, and signaling response within limited observation windows. For this reason, the non-DAC format supports research designs that compare short-acting peptide behavior with longer-acting alternatives.

Researchers value this research peptide for its clear structure and consistent composition. Its formulation allows laboratories to examine signaling activity without extended binding effects. This supports studies that rely on precision, repeatable timing, and controlled conditions.

CJC-1295 Peptide Formulation and Laboratory Handling

This research peptide is supplied as a freeze-dried powder for laboratory preparation. Researchers choose this format to support stability and flexible handling within research protocols. Lyophilized preparation also helps protect the material during storage and transport.

Before experimental use, laboratories reconstitute the powder according to internal procedures using appropriate research-grade solvents. Careful handling helps maintain peptide quality and supports reliable results across repeated studies.

For storage, laboratories should keep the material in a cool, dry place away from direct light. Proper storage conditions help preserve stability throughout the research period.

Quality Standards for Research Peptides

Each batch meets pharmaceutical-grade quality standards to support consistency and reliability in research supply. Independent testing and batch records allow researchers to review material details before use. Each shipment includes a Certificate of Analysis that supports batch verification and material clarity.

 

 

Important Notice

CJC-1295 (No DAC) is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. Qualified professionals must conduct all research in appropriate laboratory environments and in compliance with applicable regulations and guidelines.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 (no DAC) 10MG”

Your email address will not be published. Required fields are marked *

What is CJC-1295 (no DAC)?

CJC-1295 (no DAC) binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering intracellular signaling such as increased cyclic AMP (cAMP) that promotes endogenous growth hormone releaser pathways in research models. This receptor interaction is similar to that of endogenous GHRH but without extended systemic retention.

How does CJC-1295 (no DAC) compare with the DAC version?

Without the Drug Affinity Complex (DAC), CJC-1295 (no DAC) has a shorter half-life in experimental systems compared with the DAC-modified version. This results in more pulsatile receptor activation rather than prolonged receptor engagement, which is useful in research contexts where shorter signaling bursts are studied.

What biological pathways are associated with CJC-1295 (no DAC)?

Activation of the GHRH receptor by CJC-1295 (no DAC) initiates downstream pathways including cAMP/PKA signaling and subsequent peptide-linked hormone axis events. These signaling events influence patterns of growth hormone axis activity and insulin-like growth factor 1 (IGF-1) signaling in controlled research settings.

In what research models is CJC-1295 (no DAC) typically used?

CJC-1295 (no DAC) is used in in vitro and animal studies to analyze receptor pharmacology, hormone axis activation, and gene expression changes linked to growth hormone regulator pathways. Its short signaling profile makes it a useful tool for studies of pulsatile endocrine dynamics.

How does CJC-1295 (no DAC) function at a molecular level?

CJC-1295 (no DAC) binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering intracellular signaling such as increased cyclic AMP (cAMP) that promotes endogenous growth hormone releaser pathways in research models. This receptor interaction is similar to that of endogenous GHRH but without extended systemic retention.

Why is CJC-1295 (no DAC) of interest in peptide and endocrine research?

CJC-1295 (no DAC) is studied because its precise peptide sequence and receptor target allow researchers to dissect how growth hormone releaser signaling influences downstream biochemical networks. Its defined receptor interaction provides insight into endocrine signaling mechanisms and intracellular pathways tied to peptide-mediated hormone axis regulation.